Vivaldis Collaborates With Nutramax Laboratories Veterinary Sciences

Monday, July 30, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

BANGALORE, July 30, 2018 /PRNewswire/ --

Vivaldis joins hands with Nutramax Laboratories Veterinary Sciences, Inc. (Nutramax)

, a global leader in supplements to support the health of companion animals. Nutramax is committed to research and development with products backed by efficacy, bioavailability and safety trials conducted at leading veterinary schools. Nutramax
also has a number of patents and revolutionary products to their credit. With the collaboration with Nutramax, Vivaldis stands committed to its dictum to contribute to the prosperity of the pet healthcare industry by introducing pioneering products in India.

The first Nutramax product being launched is Denamarin™, the #1 veterinary recommended supplement in the U.S. for liver support for dogs and cats. Denamarin™ is a patented formula of SAMe (S-adenosylmethionine) and silybin. Formulation of SAMe is always a challenge as it is a very unstable compound and also sensitive to moisture. Nutramax, being committed to quality, safety, and efficacy, has effectively combined SAMe with SPC (silybin-phosphatidylcholine complex) by combining silybin and phosphatidylcholine, the bioavailability of silybin is increased and a more consistent absorption is achieved.

The first formal Denamarin™ launch meet was held in Bangalore on the 15th of July 2018. The seminar was arranged in association with Pet Practitioner Association of Karnataka (PPAK). This was a very successful event with more than 80 eminent veterinarians attending.

Dr. K. Jeyraja, Ph.D., Professor, Veterinary Clinical Medicine Madras Veterinary College, addressed the group on the topic, 'Diagnosis and Management of Common Hepatic Diseases in Dogs'. Various types of liver diseases of dogs, evaluation parameters and their effective management were the main focus of the entire session.

About Denamarin™

The 'two actives - one patented formula' of Denamarin is recommended for dogs and cats to support healthy liver function.

SAMe helps to increase glutathione levels, protects liver cells and protects RBCs from oxidative damage. Silybin promotes hepatocyte protein synthesis and stimulates bile flow. The combination of SAMe and Silybin makes Denamarin™ a multi-faceted approach to liver support.

Denamarin™ Indications 

1. Chronic liver disease 2. Acute liver disease 3. Canine hepatitis 4. Infectious liver disease 5. Lipidosis


Denamarin™ is available in two strengths:

1. S-AdenosylMethionine (SAMe) 225 mg with Silybin-phosphatidylcholine complex 82 mg providing 24mg of Silybin A+B 2. S-AdenosylMethionine (SAMe) 425 mg with Silybin-phosphatidylcholine complex 120 mg providing 35mg of Silybin A+B

About Vivaldis Health & Foods Pvt. Ltd  

Vivaldis is a leading animal healthcare company based in Pune. It was born out of the vision of professionals who are passionate about animal and human healthcare. The company plays an active role in the care, cure and management of animal health by introducing innovative and ground-breaking treatment options. The product portfolio comprises global brands like Cosequin™ for joint health, other unique formulations for gastrointestinal problems and dermatological conditions, and range of lifestyle disease management products with Molecular Activation Technology. Enzyme-based novel formulations, duly supported by the routine formulations for infection and infestation control are also available that maximise health, agility, productivity and performance of companion animals.

Media Contact : Ms. Sharvari Raut +91-7741978949 Vivaldis Health & Foods Pvt. Ltd

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store